| Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ... Nucleic acids research 48 (21), 11827-11844, 2020 | 165 | 2020 |
| Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2 K Schmidt, DM Wolfe, B Stiller, DA Pearce Biochemical and biophysical research communications 383 (2), 198-202, 2009 | 159 | 2009 |
| Nuclear RNA surveillance: role of TRAMP in controlling exosome specificity K Schmidt, JS Butler Wiley Interdisciplinary Reviews: RNA 4 (2), 217-231, 2013 | 123 | 2013 |
| The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like region K Schmidt, CE Joyce, F Buquicchio, A Brown, J Ritz, RJ Distel, CH Yoon, ... Cell reports 15 (9), 2025-2037, 2016 | 113 | 2016 |
| The lncRNA SLNCR recruits the androgen receptor to EGR1-bound genes in melanoma and inhibits expression of tumor suppressor p21 K Schmidt, JS Carroll, E Yee, DD Thomas, L Wert-Lamas, SC Neier, ... Cell reports 27 (8), 2493-2507. e4, 2019 | 67 | 2019 |
| Targeting the oncogenic long non-coding RNA SLNCR1 by blocking its sequence-specific binding to the androgen receptor K Schmidt, CA Weidmann, TA Hilimire, E Yee, BM Hatfield, ... Cell reports 30 (2), 541-554. e5, 2020 | 52 | 2020 |
| Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial AM Sonabend, A Gould, C Amidei, R Ward, KA Schmidt, DY Zhang, ... The Lancet Oncology 24 (5), 509-522, 2023 | 46 | 2023 |
| The nonclinical disposition and pharmacokinetic/pharmacodynamic properties of N-Acetylgalactosamine–conjugated small interfering RNA are highly predictable and build confidence … R McDougall, D Ramsden, S Agarwal, S Agarwal, K Aluri, M Arciprete, ... Drug Metabolism and Disposition 50 (6), 781-797, 2022 | 37 | 2022 |
| Air proteins control differential TRAMP substrate specificity for nuclear RNA surveillance K Schmidt, Z Xu, DH Mathews, JS Butler Rna 18 (10), 1934-1945, 2012 | 37 | 2012 |
| The nonclinical disposition and PK/PD properties of GalNAc-conjugated siRNA are highly predictable and build confidence in translation to man S Chong, S Agarwal, S Agarwal, KC Aluri, M Arciprete, C Brown, ... Drug Metabolism and Disposition, 2021 | 19 | 2021 |
| Analysis of non-typeable Haemophilous influenzae VapC1 mutations reveals structural features required for toxicity and flexibility in the active site B Hamilton, A Manzella, K Schmidt, V DiMarco, JS Butler PLoS One 9 (11), e112921, 2014 | 14 | 2014 |
| Interobserver reproducibility of visually interpreted EGFR immunohistochemical staining in non-small-cell lung cancer M Janas, WA Franklin, K Schmidt, LR Bailey Proc Am Assoc Cancer Res 44, abstrLB-213, 2003 | 6 | 2003 |
| Compositions and methods for treating AR- and/or lncRNA-mediated diseases CN Karyn A Schmidt | 4* | |
| RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes M Subramanian, J McIninch, I Zlatev, MK Schlegel, C Kaittanis, T Nguyen, ... Nature Communications 14 (1), 1970, 2023 | 3 | 2023 |
| RATA: A method for high-throughput identification of RNA bound transcription factors K Schmidt, F Buquicchio, JS Carroll, RJ Distel, CD Novina Journal of biological methods 4 (1), 2017 | 3 | 2017 |
| Compositions and methods for identification, assessment, prevention, and treatment of cancer using slncr isoforms K Schmidt, C Novina US Patent App. 15/741,317, 2019 | 2 | 2019 |
| Rational optimization of siRNA to ensure strand bias in the interaction with the RNA-induced silencing complex D Datta, CS Theile, K Wassarman, J Qin, T Racie, K Schmidt, Y Jiang, ... Chemical Communications 59 (42), 6347-6350, 2023 | 1 | 2023 |
| NAR Breakthrough Article Investigating the pharmacodynamic durability of CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ... Nucleic Acids Research 48 (21), 11827-11844, 2020 | 1 | 2020 |
| Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using SLNCR Isoforms KSCD Novina US Patent PCT/US2016/041,343, 2017 | | 2017 |
| Cd {sup 2+}, Mn {sup 2+}, Ni {sup 2+} and Se {sup 2+} toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2 K Schmidt, DM Wolfe, B Stiller Biochemical and Biophysical Research Communications 383 (2), 2009 | | 2009 |
